Commission Implementing Regulation (EU) 2017/173 of 1 February 2017 amending Regulation (EC) No 1292/2008 and Implementing Regulation (EU) No 887/2011, as regards the name of the holder of the authorisation of Bacillus amyloliquefaciens CECT 5940 and Enterococcus faecium CECT 4515 (Text with EEA relevance. )

• CELEX: Implementing Regulation (EU) 2017/173
• Articles: 4

Article 1 Amendment to Regulation (EC) No 1292/2008

In column 2 of the Annex to Regulation (EC) No 1292/2008 the term ‘Norel SA’ is replaced by the term ‘Evonik Nutrition & Care GmbH’.

Article 2 Amendment to Implementing Regulation (EU) No 887/2011

Implementing Regulation (EU) No 887/2011 is amended as follows:

(a)

in the title, the term ‘Norel SA’ is replaced by the term ‘Evonik Nutrition & Care GmbH’;

(b)

in column 2 of the Annex, the term ‘Norel SA’ is replaced by the term ‘Evonik Nutrition & Care GmbH’.

Article 3 Transitional measures

Existing stocks of the additives which are in conformity with the provisions applying before the date of entry into force of this Regulation may continue to be placed on the market and used until they are exhausted.

Article 4 Entry into force

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .